Clinical Trial Update: Cost-Effectiveness Study in the Reduction of Coronary Restenosis With Sirolimus-Eluting Stents [Phase 4]

View source ↗

Summary

A Phase 4 cost-effectiveness study evaluated the economic impact of sirolimus-eluting stents in reducing coronary restenosis in coronary artery disease, and the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Sirolimus-eluting stents (sirolimus-eluting stent)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED